INTS8
Basic information
Region (hg38): 8:94813311-94881746
Previous symbols: [ "C8orf52" ]
Links
Phenotypes
GenCC
Source:
- neurodevelopmental disorder with cerebellar hypoplasia and spasticity (Limited), mode of inheritance: AR
- neurodevelopmental disorder with cerebellar hypoplasia and spasticity (Limited), mode of inheritance: Unknown
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the INTS8 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 9 | |||||
missense | 38 | 43 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 2 | 2 | ||||
non coding | 3 | |||||
Total | 0 | 1 | 40 | 11 | 5 |
Variants in INTS8
This is a list of pathogenic ClinVar variants found in the INTS8 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-94822929-A-G | Benign (Feb 01, 2023) | |||
8-94823547-G-T | not specified | Uncertain significance (Nov 25, 2024) | ||
8-94824884-A-G | INTS8-related disorder | Benign (Nov 19, 2019) | ||
8-94824920-A-T | not specified | Uncertain significance (Jun 11, 2021) | ||
8-94824926-TG-T | Malignant tumor of prostate | Uncertain significance (-) | ||
8-94824972-A-C | not specified | Uncertain significance (May 31, 2023) | ||
8-94824989-A-G | not specified | Uncertain significance (Oct 12, 2022) | ||
8-94825062-G-A | INTS8-related disorder | Likely benign (Dec 23, 2019) | ||
8-94827290-A-G | Likely benign (Jun 01, 2020) | |||
8-94827354-G-A | not specified | Uncertain significance (Dec 20, 2021) | ||
8-94827369-A-G | not specified | Uncertain significance (Aug 27, 2024) | ||
8-94827759-A-C | Long QT syndrome | Likely benign (-) | ||
8-94827773-C-T | Likely benign (May 09, 2018) | |||
8-94827774-G-A | not specified | Uncertain significance (Jun 30, 2022) | ||
8-94829015-A-G | not specified | Uncertain significance (Sep 28, 2022) | ||
8-94832018-T-G | not specified | Uncertain significance (Aug 01, 2024) | ||
8-94832137-C-T | not specified | Uncertain significance (Nov 14, 2023) | ||
8-94832142-T-A | not specified | Uncertain significance (Jun 07, 2024) | ||
8-94832152-A-C | not specified | Uncertain significance (Dec 21, 2023) | ||
8-94832157-G-A | not specified | Uncertain significance (Oct 16, 2023) | ||
8-94838474-A-G | INTS8-related disorder | Likely benign (-) | ||
8-94838494-A-G | Neurodevelopmental disorder with cerebellar hypoplasia and spasticity | Pathogenic (Sep 11, 2019) | ||
8-94838502-C-T | not specified | Uncertain significance (Mar 16, 2022) | ||
8-94838545-C-T | not specified | Uncertain significance (Apr 07, 2023) | ||
8-94838590-A-G | not specified | Uncertain significance (Nov 14, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
INTS8 | protein_coding | protein_coding | ENST00000523731 | 27 | 68436 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.944 | 0.0561 | 125727 | 0 | 21 | 125748 | 0.0000835 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.03 | 384 | 513 | 0.748 | 0.0000253 | 6523 |
Missense in Polyphen | 120 | 201.16 | 0.59653 | 2587 | ||
Synonymous | -0.0832 | 182 | 181 | 1.01 | 0.00000922 | 1841 |
Loss of Function | 5.88 | 12 | 62.0 | 0.194 | 0.00000326 | 755 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000622 | 0.0000615 |
Ashkenazi Jewish | 0.000107 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000134 | 0.000132 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Component of the Integrator complex, a complex involved in the small nuclear RNAs (snRNA) U1 and U2 transcription and in their 3'-box-dependent processing. The Integrator complex is associated with the C-terminal domain (CTD) of RNA polymerase II largest subunit (POLR2A) and is recruited to the U1 and U2 snRNAs genes.;
- Pathway
- Gene expression (Transcription);RNA polymerase II transcribes snRNA genes;RNA Polymerase II Transcription
(Consensus)
Recessive Scores
- pRec
- 0.132
Intolerance Scores
- loftool
- rvis_EVS
- -0.57
- rvis_percentile_EVS
- 18.9
Haploinsufficiency Scores
- pHI
- 0.150
- hipred
- Y
- hipred_score
- 0.694
- ghis
- 0.587
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.772
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ints8
- Phenotype
Gene ontology
- Biological process
- snRNA processing;snRNA 3'-end processing;snRNA transcription by RNA polymerase II
- Cellular component
- nucleoplasm;integrator complex
- Molecular function
- protein binding